Lobeglitazone, A Peroxisome Proliferator-Activated Receptor-Gamma Agonist, Inhibits Papillary Thyroid Cancer Cell Migration and Invasion by Suppressing p38 MAPK Signaling PathwayJun-Qing Jin, Dong‐Jun Lim|Endocrinology and Metabolism|2021Cited by 17